Bioluminescent protease assay

Details Bioluminescent protease assay Bioluminescent protease assay

2010-02-16

2011-12-06

Gitomer, Ralph (Department: 1657)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving hydrolase

C435S008000, C530S335000

Reexamination Certificate

active

08071328

ABSTRACT:
A sensitive bioluminescent assay to detect proteases including caspases, trypsin and tryptase is provided.

REFERENCES:
patent: 4557862 (1985-12-01), Mangel et al.
patent: 4640893 (1987-02-01), Mangel et al.
patent: 4908309 (1990-03-01), Cho et al.
patent: 5035999 (1991-07-01), Geiger et al.
patent: 5098828 (1992-03-01), Geiger et al.
patent: 5314805 (1994-05-01), Haugland et al.
patent: 5698411 (1997-12-01), Lucas et al.
patent: 5744320 (1998-04-01), Sherf et al.
patent: 5834196 (1998-11-01), Reutelingsperger
patent: 5976822 (1999-11-01), Landrum et al.
patent: 6251614 (2001-06-01), Fritz et al.
patent: 6270980 (2001-08-01), Fritz et al.
patent: 6335429 (2002-01-01), Cai et al.
patent: 6586196 (2003-07-01), Bronstein et al.
patent: 6602657 (2003-08-01), Bronstein et al.
patent: 6613541 (2003-09-01), Vaddi et al.
patent: 6759207 (2004-07-01), Weber et al.
patent: 6811990 (2004-11-01), Corey et al.
patent: 6890745 (2005-05-01), Leng
patent: 7148030 (2006-12-01), O'Brien et al.
patent: 7384758 (2008-06-01), O'Brien et al.
patent: 7416854 (2008-08-01), Riss et al.
patent: 7553632 (2009-06-01), Niles et al.
patent: 7666987 (2010-02-01), O'Brien et al.
patent: 2002/0068316 (2002-06-01), Rust et al.
patent: 2002/0119500 (2002-08-01), Xue et al.
patent: 2004/0171099 (2004-09-01), Cali et al.
patent: 2008/0268482 (2008-10-01), Riss et al.
patent: 2009/0017482 (2009-01-01), Riss et al.
patent: 2009/0275051 (2009-11-01), Niles et al.
patent: 199878177 (1998-12-01), None
patent: 1382691 (2004-01-01), None
patent: 63501571 (1988-06-01), None
patent: 2001519368 (1999-04-01), None
patent: 11341998 (1999-12-01), None
patent: 2000513563 (2000-10-01), None
patent: WO 88/05434 (1988-07-01), None
patent: WO 00/36098 (2000-06-01), None
patent: WO 00/50630 (2000-08-01), None
patent: WO 00/52194 (2000-09-01), None
patent: WO 01/46694 (2001-06-01), None
patent: WO 01/57242 (2001-08-01), None
patent: WO 02/00882 (2002-01-01), None
patent: WO 02/06458 (2002-01-01), None
patent: WO 02/12547 (2002-02-01), None
patent: WO 03/025192 (2003-03-01), None
patent: WO 03/066611 (2003-08-01), None
patent: WO 2005/073722 (2005-08-01), None
patent: WO 2007/027653 (2007-03-01), None
patent: WO 2008/127677 (2008-10-01), None
Monsees T. et al. Synthesis and Characterization of a Bioluminogenic Substrate for Alpha Chymotrypsin. Analytical Biochem 221(2)329-334, 1994.
Monsees T. et al. A Novel Bioluminogenic Assay for Alpha Chymotrypsin. J Biolumin Chemilumin (England) 10(4)213-218, Jul. 1995.
“Apo-ONE homogeneous caspase-3/7 assay,” Promega Online Catalog, www.promega.com (Jun. 2, 2003) 2 pages.
“Apo-ONE Homogeneous Caspase-3/7 Assay,” Promega Technical Bulletin No. 295 (Part # TB295) May 2001, 12 pages.
“Apoptosis inducers and the assay of caspase activity biomol,” Fased Journal, Abstract No. T10, Federation of American Studies for Experiemental Biology (1998) 2(80:A1488.
“Apoptosis: Annexin V and Propidium Iodide—freedom to discovery,” Acumen Bioscience Ltd. (prior to Jan. 20, 2004) 2 pages.
“Beadlyte® Multiplex Assay Systems,” Product Guide, Upstate Cell Signalling Solutions (2002) 12 pages.
“Caspase-Glo™ 3/7 Assay,” Technical Bulletin No. 323, Promega Corporation, May 2003 (13 pages).
“Cell Cytotoxicity—Freedom to Discover,” Acumen Bioscience Ltd. (Prior to Jan. 20, 2004) 2 pages.
“Cell Proliferation—Freedom to Discover,” Acumen Bioscience Ltd. (Prior to Jan. 22, 2004) 2 pages.
“CellTiter-Blue™ Cell Viability Assay,” Technical Bulletin No. 317, Promega Corporation (Dec. 2002) 12 pages.
“CellTiter-Glo™ Luminescent Cell Viability Assay,” Technical Bulletin No. 288, Promega Corporation (May 2001) 11 pages.
“CleavaLite: New bioluminescent caspase-3 activity assay,” Chemicon Intl. Commun. Update (Published before May 15, 2001) 11(2):1 page.
“Cyto-Tox-ONE™ Homogeneous Membrane Integrity Assay,” Technical Bulletin No. 306, Promega Corporation (May 2003) 13 pages.
“Dual-Light® Luminescent Report Gene Assay for Luciferase and Beta-Galactosidase,” Data Sheet, Applied Biosystems (2000) 2 pages).
“Multiplex Antibody Kits Custom Software & Hardware for Luminex™,” MiraiBio Inc. (Prior to Jan. 20, 2004) 2 pages.
“New Products—ApoAlert CPP32 Protease Assay Kits,” CLONTECHniques (Jan. 1997) 4-6.
“UniCAP tryptase,” http://www.labspec.co.za/tryptase.html (Jan. 2002) 6 pages.
Adrain, C. et al., “Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2,” The EMBO J. (2001) 20(23):6627-6636.
Armstrong, R.C. et al., “Activation of the CED3/ICE-related protease CPP332 in cerebellar granule neurons undergoing apoptosis but not necrosis,” J. Neurosci. (1997) 17(2):553-562.
Batchlor, R.H. et al., “Use of cellular glucose-6-phosphate dehydrogenase for cell quantitation: applications in cytotoxicity and apoptosis assays,” Anal. Biochem. (2004) 329(1):35-42.
Berkers, C.R. et al., “Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib,” Nature Meth. (2005) 2(5):357-362.
Bond, J.S. et al., “Intracellular proteases,” Ann. Rev. Biochem. (1987) 56:333-364.
Bronstein, I. et al., “Combined luminescent assays for multiple enzymes,” Bioluminescence and Chemiluminescence: Molecular Reporting With Photons (International Symposium Proceedings (1997) 451-457.
Chang, H.Y. et al., “Proteases for cell suicide: functions and regulation of caspases,” Microbiol. Mol. Biol. Reviews (2000) 46:821-846.
Constam, D.B. et al., “Purumycin-sensitive aminopeptidase,” J. Biol. Chem. (1995) 270(45):26931-26939.
Cook, J.A. et al., “Viability measurements in mammalian cell system,s” Anal. Biochem. (1989) 179:1-7.
Damour, M. et al., “Non-radioactive multiplex kinase activity assay using Beadlyte® Suspension Microarrays,” (Prior to Jan. 20, 2004) 1 page.
De Jager, W. et al., “Simultaneous detectin of 15 human cytokines in a single sample of stimulated peripheral blood mononucelar cels,” Clin. Diagnos. Lab. Immunol. (2003) 10(1):133-139.
Dyer, B. et al., “A noncommercial dual luciferase enzyme assay system for report gene analysis,” Anal. Biochem. (2000) 282:158-161.
Farfan, A. et al., “Frequently asked questions Cytotox-One™ homogeneous membrane integrity assay,” Cell Notes (2003) 6:19-20.
Fenteany, G. et al., “Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin,” Science (1995) 268(5211):726-731.
Fernandes-Alnemri, T. et al., “In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains,” Proceedings of NAS USA (1996) 93:7464-7469.
Fernandez, Y. et al., “Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications,” Cancer Res. (2005) 65(14):6294-6304.
Garcia-Calvo, M. et al., “Purification and catalytic properties of human caspase family members,” Cell Death & Differentiation (1999) 6(4):362-369.
Grant et al., “Development of novel assays for proteolytic enzymes using rhodamine-based fluorogenic substrates,” J. Biomol. Screening (2002) 7(6):531-540.
Gurtu, V. et al., “Fluorometric and colorimetric detection of caspase activity associated with apoptosis,” Anal. Biochem. (1997) 251:98-102.
Haunstetter, A. et al., “Apoptosis: basic mechanisms and implications for cardiovascular disease,” Circul. Res. (1998) 82:111-1129.
Karlsson, J.O. et al., “Proteolytic activity in intact sheets of polarized epithelial cells as determined by a cell-permeable fluorogenic substrate,” Cell Biol. Int. (2000) 24(4):235-243.
Kiss

Affiliated with

Also associated with

Rating

Bioluminescent protease assay does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bioluminescent protease assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioluminescent protease assay will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4265962